Skip to main content
. Author manuscript; available in PMC: 2020 Jan 28.
Published in final edited form as: J Control Release. 2018 Dec 18;294:216–225. doi: 10.1016/j.jconrel.2018.12.027

Figure 1.

Figure 1.

The TFV (black) and FTC (red) concentration-time curves in vagina (A), respective active metabolites i.e. TFV-dp (black) and FTC-tp (red) in PBMCs (B), plasma (C), colon (D), obtained from hu-NSG mice receiving each drug at 200 mg/kg as TAF+FTC NP and the respective insert graphs presents the same studies on mice that received each drug at 200 mg/kg as TAF+FTC solution.